Fixed-dose combination

Results: 323



#Item
111HIV Drug Assistance Program

HIV Drug Assistance Program

Add to Reading List

Source URL: www.ok.gov

Language: English - Date: 2014-09-15 15:17:10
112Phase 3 UNITY Trials Demonstrate High Cure Rates for Investigational, All-Oral Daclatasvir TRIO Fixed-Dose Combination in Genotype 1 Hepatitis C Patients, Including Those with Cirrhosis Daclatasvir TRIO achieves 98% cure

Phase 3 UNITY Trials Demonstrate High Cure Rates for Investigational, All-Oral Daclatasvir TRIO Fixed-Dose Combination in Genotype 1 Hepatitis C Patients, Including Those with Cirrhosis Daclatasvir TRIO achieves 98% cure

Add to Reading List

Source URL: www.hepcassoc.org

Language: English - Date: 2014-11-10 11:48:36
113NDA[removed]Nebivolol/Valsartan Fixed-Dose Combination  Forest Research Institute, Inc. Page 2 of 116

NDA[removed]Nebivolol/Valsartan Fixed-Dose Combination Forest Research Institute, Inc. Page 2 of 116

Add to Reading List

Source URL: www.fda.gov

Language: English
114NDA 206,302 (Nebivolol/Valsartan Fixed Dose Combination)

NDA 206,302 (Nebivolol/Valsartan Fixed Dose Combination)

Add to Reading List

Source URL: www.fda.gov

Language: English
115World Health Organization 2007 All rights reserved. The document may not be reviewed, abstracted, quoted, reproduced, transmitted, distributed, translated or adapted, in part or in whole, in any form or by any means

World Health Organization 2007 All rights reserved. The document may not be reviewed, abstracted, quoted, reproduced, transmitted, distributed, translated or adapted, in part or in whole, in any form or by any means

Add to Reading List

Source URL: apps.who.int

Language: English - Date: 2007-11-29 06:59:40
116Oklahoma HDAP Formulary effective[removed]FY 2014 Oklahoma HIV Drug Assistance Program Drug Formulary Brand Generic Aptivus

Oklahoma HDAP Formulary effective[removed]FY 2014 Oklahoma HIV Drug Assistance Program Drug Formulary Brand Generic Aptivus

Add to Reading List

Source URL: www.ok.gov

Language: English - Date: 2014-09-15 15:15:59
117WHO Prequalification Team Medicines (PQT-M) Guidance Document 30 September 2014

WHO Prequalification Team Medicines (PQT-M) Guidance Document 30 September 2014

Add to Reading List

Source URL: apps.who.int

Language: English - Date: 2014-09-29 08:36:12
118SOGC CLINICAL PRACTICE GUIDELINE No. 310, August 2014 Guidelines for the Care of Pregnant Women Living With HIV and Interventions to Reduce Perinatal Transmission

SOGC CLINICAL PRACTICE GUIDELINE No. 310, August 2014 Guidelines for the Care of Pregnant Women Living With HIV and Interventions to Reduce Perinatal Transmission

Add to Reading List

Source URL: sogc.org

Language: English - Date: 2014-09-25 08:34:19
119HIGHLIGHTS OF PRESCRIBING INFORMATION  • New onset or worsening renal impairment: Can include acute renal failure and Fanconi syndrome. Assess estimated creatinine

HIGHLIGHTS OF PRESCRIBING INFORMATION • New onset or worsening renal impairment: Can include acute renal failure and Fanconi syndrome. Assess estimated creatinine

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2013-11-05 15:14:28
120CrCl is below 60 mL/min. If a decrease in CrCl is observed in uninfected individuals while using TRUVADA for PrEP, evaluate potential causes and re-assess potential risks and benefits of continued use[removed]HIGHLIGHTS

CrCl is below 60 mL/min. If a decrease in CrCl is observed in uninfected individuals while using TRUVADA for PrEP, evaluate potential causes and re-assess potential risks and benefits of continued use[removed]HIGHLIGHTS

Add to Reading List

Source URL: www.gilead.com

Language: English - Date: 2013-12-17 08:54:34